Skip to main content

Table 3 Fibroblast growth factor 23 quartiles and hazard ratios with 95% confidence interval for long-term mortality adjusted for age, ejection fraction and baseline serum lactate

From: Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Overall cohort

1

1.02

1.59

2.34

(0.44–2.37)

(0.78–3.24)

(1.12–4.88)

Creatinine ≥117 μmol/L

1

1.11

2.78

3.56

(0.17–7.06)

(0.61–12.62)

(0.81–15.72)

Creatinine <117 μmol/L

1

0.89

0.95

1.42

(0.33–2.38)

(0.36–2.49)

(0.30–6.82)